| Business Summary | | CardioDynamics
International
Corporation
is
a
medical
technology
and
information
solutions
company
that
develops,
manufactures
and
markets
non-invasive
heart-monitoring
devices
using
the
Company's
proprietary
impedance
cardiography
(ICG)
technology,
DISQ
technology
and
ZMarc
algorithm.
The
Company's
proprietary,
patented
technology
non-invasively
monitors
the
heart's
ability
to
deliver
blood
to
the
body.
CardioDynamics'
products
measure
12
hemodynamic
(blood
flow)
parameters,
the
most
significant
of
which
is
cardiac
output,
or
the
amount
of
blood
pumped
by
the
heart
each
minute.
The
Company's
products
help
physicians
assess,
diagnose
and
treat
cardiovascular
disease.
CardioDynamics'
ICG
technology
non-invasively
quantifies
the
mechanical
functioning
of
the
heart. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | CardioDynamics
International
is
a
medical
technology
and
information
solutions
company
that
develops,
manufactures
and
markets
noninvasive
heart-monitoring
devices
which
provide
continuous
data
on
a
wide
range
of
hemodynamic
parameters.
For
the
six
months
ended
5/31/01,
sales
rose
48%
to
$8.4
million.
Net
loss
fell
9%
to
$964
thousand.
Results
reflect
expansion
of
the
domestic
direct
sales
force,
offset
by
additional
personnel
and
enhancement
to
the
BioZ.com
systems. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| James Gilstrap, 65 Chairman | -- | -- | Michael Perry, 40 CEO,
Director | $226K | $1.0M | Rhonda Rhyne, 40 Pres | 212K | 391K | Stephen Loomis, 40 CFO,
Sec. | 147K | 385K | Richard Trayler, 49 COO | 132K | 54K | Dollar amounts are as of 30-Nov-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|